Patients/ Arrays | Individual or Mixed | Age (years) | Stage of histopathology | Scaling Factor | % Present Calls | % Diff Calls Paired samples | Four comparisons > 2-fold changes relative to controls 1a, 1b |
---|---|---|---|---|---|---|---|
1a | Ind | 5.5 | mid | 1.08 | 51 | 5.6 | 302 |
1b | Â | Â | Â | 0.9 | 50 | Â | Â |
2a | Ind | 4.5 | early stage | 1.93 | 38 | 3 | 427 |
2b | Â | Â | Â | 3.28 | 36 | Â | Â |
3a | Ind | 5 | early/mid stage | 0.53 | 49 | 8.6 | 312 |
3b | Â | Â | Â | 0.97 | 44 | Â | Â |
3a-dup | Ind | 5 | early/mid stage | 0.46 | 50 | 0.8 | N/A |
3b-dup | Â | Â | Â | 0.82 | 46 | 2.1 | Â |
4a | Ind | 6 | mid | 0.78 | 51 | 18 | 324 |
4b | Â | Â | Â | 1.02 | 50 | Â | Â |
5a | Ind | 5 | early | 1.26 | 51 | 6.2 | 453 |
5b | Â | Â | Â | 2.13 | 40 | Â | Â |
6a | Ind | 12 | mid | 2.72 | 35 | 1.5 | 305 |
6b | Â | Â | Â | 2.46 | 38 | Â | Â |
7a | Ind | 11 | mid/moderate | 0.79 | 51 | 2.6 | 356 |
7b | Â | Â | Â | 0.9 | 49 | Â | Â |
8a | Ind | 10 | mid | 1.24 | 49 | 1.5 | 463 |
8b | Â | Â | Â | 1.74 | 50 | Â | Â |
9a | Ind | 11 | variable | 1.04 | 50 | 8.5 | 266 |
9b | Â | Â | Â | 1.37 | 46 | Â | Â |
10a | Ind | 10 | mid/late | 0.48 | 52 | 1.5 | 250 |
10b | Â | Â | Â | 0.75 | 48 | Â | Â |
6-9mix-1a | mix | 6 to 9 | 5 patients biopsies, cRNAs mixed | 0.82 | 49 | 3.2 | 289 |
6-9mix-1b | mix | Â | Â | 1.16 | 55 | Â | Â |
5-6mix-1a | mix | 5 to 6 | 5 patients biopsies, cRNAs mixed | 0.67 | 60 | 0.5 | 486 |
5-6mix-1b | mix | Â | Â | 1.03 | 58 | Â | Â |
10-12mix-1a | mix | 10 to 12 | 5 patients biopsies, cRNAs mixed | 0.82 | 49 | 0.4 | 388 |
10-12mix-1b | mix | Â | Â | 1.16 | 55 | Â | Â |
control 1a | mix | 6 to 9 | 5 normal biopsies, cRNAs mixed | 0.71 | 53 | 1.5 | N/A |
control 1b | mix | Â | Â | 0.48 | 54 | Â | Â |
control 2a | mix | 5 to 12 | 3 normal biopsies, cRNAs mixed | 0.86 | 54 | 0.8 | N/A |
control 2b | mix | Â | Â | 0.78 | 53 | Â | Â |
control 3a | mix | 4 to 13 | 3 normal biopsies, cRNAs mixed | 0.95 | 51 | 1.1 | N/A |
control 3b | mix | Â | Â | 0.78 | 55 | Â | Â |